CHD/Prevention

Top Story

Many statin-naive patients benefit from adding ezetimibe to statin therapy

Many statin-naive patients benefit from adding ezetimibe to statin therapy
May 25, 2016

NEW ORLEANS — In patients recommended by guideline for statin therapy who had never before taken statins, ezetimibe was often needed in addition to statins to achieve LDL goals, according to an analysis presented at the National Lipid Association Scientific Sessions.

Researchers pooled data from 14 randomized, controlled, double blind trials of patients with hypercholesterolemia who were statin-naive.

Meeting News Coverage

Patients with familial chylomicronemia syndrome at high risk for acute pancreatitis

May 24, 2016
NEW ORLEANS — Patients with familial chylomicronemia syndrome, a rare lipid disorder, have an increased risk for acute pancreatitis, researchers reported at the…
Meeting News Coverage

PCSK9 inhibitors benefit patients with residual LDL burden

May 24, 2016
NEW ORLEANS — A leading authority on PCSK9 inhibitors told the audience at the National Lipid Association Scientific Sessions that while the drugs can lower LDL by…
Meeting News Coverage

Successful lipid-lowering drug development requires thorough, diverse research

May 23, 2016
NEW ORLEANS — Lipid-lowering therapies face a number of challenges in getting FDA approval, but those with the strongest evidence will succeed in making it to the…
CME

CARDIOVASCULAR CONSULTS®: Volume 1, Number 1

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Heart failure is a complex clinical syndrome that constitutes a major morbidity and mortality burden and stress on the…
More »
Video
Meeting News Coverage

VIDEO: MI with nonobstructive coronary arteries a key focus area in women’s heart health

April 19, 2016
More »
Featured
Highlights from ACC Scientific Session

Highlights from ACC Scientific Session

Video
Meeting News Coverage

VIDEO: Familial hypercholesterolemia presents ‘terrible paradox’

May 22, 2016
More »
Meeting News Coverage

Many statin-naive patients benefit from adding ezetimibe to statin therapy

May 25, 2016
NEW ORLEANS — In patients recommended by guideline for statin therapy who had never before taken statins, ezetimibe was often needed in…

Meeting News Coverage

Patients with familial chylomicronemia syndrome at high risk for acute pancreatitis

May 24, 2016
NEW ORLEANS — Patients with familial chylomicronemia syndrome, a rare lipid disorder, have an increased risk for acute pancreatitis…

Meeting News Coverage

PCSK9 inhibitors benefit patients with residual LDL burden

May 24, 2016
NEW ORLEANS — A leading authority on PCSK9 inhibitors told the audience at the National Lipid Association Scientific Sessions that while the…

Meeting News Coverage

Successful lipid-lowering drug development requires thorough, diverse research

May 23, 2016
NEW ORLEANS — Lipid-lowering therapies face a number of challenges in getting FDA approval, but those with the strongest evidence will succeed…

Meeting News CoverageVideo

VIDEO: New NLA president outlines organization’s accomplishments, goals

May 23, 2016
NEW ORLEANS — In this video from the National Lipid Association Scientific Sessions, the newly elected president of the NLA, Joyce Ross, MSN

Meeting News CoverageVideo

VIDEO: Familial hypercholesterolemia presents ‘terrible paradox’

May 22, 2016
NEW ORLEANS — In this video, Joshua W. Knowles, MD, PhD, FAHA, FACC, assistant professor of cardiovascular medicine at Stanford University;…

Meeting News Coverage

Intensive lipid-lowering therapy reduces mortality over 25 years

May 22, 2016
NEW ORLEANS — A regimen of intensive lipid-lowering therapy for 25 years was associated with reduction in CV and all-cause mortality, according…

Meeting News Coverage

Evolocumab yields lower cost per effectively treated patient vs. alirocumab

May 22, 2016
NEW ORLEANS — The cost per effectively treated patient was lower with the PCSK9 inhibitor evolocumab compared with alirocumab over a 1-year…

Meeting News CoverageVideo

VIDEO: Expert discusses uncommon dyslipidemias with common presentations

May 21, 2016
NEW ORLEANS — In this video from the National Lipid Association Scientific Sessions, James Underberg, MD, MS, FACP, FNLA, discusses his…

Meeting News Coverage

High nut consumption linked with reduction in CHD risk among women

May 21, 2016
NEW ORLEANS — In an analysis of the Women’s Health Study, increased consumption of nuts was associated with reduced risk for CHD.However…

More Headlines »